注射庆大霉素对梅尼埃病的疗效及对患者听力的影响

发布时间：2018-01-01 17:01

本文关键词：注射庆大霉素对梅尼埃病的疗效及对患者听力的影响　出处：《中国医学创新》2016年31期 　论文类型：期刊论文

【摘要】：目的:探讨注射庆大霉素对梅尼埃病的疗效及对患者听力的影响。方法:选取本院2011年4月-2013年4月收治的80例梅尼埃患者,依据抽签法分为对照组和试验组,每组各40例,对照组患者予以地塞米松治疗,试验组患者予以注射庆大霉素治疗,观察两组患者治疗后的听力变化、眩晕及耳鸣的控制效果,不良反应。结果:治疗后,两组梅尼埃病患者4、8 KHz听阈均有一定降低,但两组比较差异均无统计学意义(P0.05)。试验组眩晕总有效率90.00%高于对照组72.50%,两组比较差异有统计学意义(P0.05);试验组耳鸣总有效率67.50%高于对照组45.00%,比较差异有统计学意义(P0.05),两组患者总不良反应率比较无差异(P0.05)。结论:射庆大霉素对于梅尼埃病患者的效果确切,能够显著改善患者的眩晕症状,对于耳鸣也有一定的改善效果,同时对于患者的听力影响较小,值得推广。
[Abstract]:Objective: to investigate the effect of gentamicin injection on Meniere's disease and its effect on hearing. Methods: 80 patients with Meniere's disease from April 2011 to April 2013 were selected. According to the method of drawing lots, the patients in each group were divided into two groups, 40 cases in each group. The patients in the control group were treated with dexamethasone, and the patients in the experimental group were treated with gentamicin injection. The hearing changes of the two groups were observed after treatment. Results: after treatment, the hearing threshold of 48 KHz in patients with Meniere's disease was decreased to a certain extent. The total effective rate of vertigo in the test group was 90.00% higher than that in the control group (72.50%), and the difference between the two groups was statistically significant (P 0.05). The total effective rate of tinnitus in the test group was 67.50% higher than that in the control group (P 0.05). There was no difference in total adverse reaction rate between the two groups (P 0.05). Conclusion: the effect of gentamicin on patients with Meniere's disease is accurate, and can significantly improve the vertigo symptoms of patients with Meniere's disease. For tinnitus also has certain improvement effect, at the same time to the patient's hearing influence is small, is worth popularizing.
【作者单位】：江西省赣州市人民医院(南昌大学附属赣州医院);
【分类号】：R764.33
【正文快照】： 梅尼埃病作为一种内耳疾病,多发生于中年人1.2　纳入与排除标准　纳入标准:(1)符合《梅尼群,且多为单侧发病,主要临床表现为突发性的眩埃病的诊断与疗效评价标准》中相关诊断标准[6]:晕、耳鸣、眼球震颤,发作时患者可出现面色苍白、(1)反复发作性、旋转性、自发性眩晕,2次及以

【相似文献】